Schedule 13D ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M204
Event date: 2025-03-25
- Filing-level shares
- 1,028,086
- Percent of class
- 27.9%
- Peter M. HechtReported CIK 0001478485
Shares: 1,028,086 · Class: 27.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-047124
- Form type
- SCHEDULE 13D/A
- Filer
- Cyclerion Therapeutics, Inc.
- CIK
- CIK 1755237
- Filed
- Mar 28, 2025
- Reporting period
- Mar 25, 2025
- Description
- Schedule 13D beneficial ownership